Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue September 2014
 •  Univar Signs Deal With Evonik  •  New App Brings Beauty on Demand  •  Estee Lauder Names Senior Vice President  •  Beauty & the East  •  US Senate OKs Sunscreen Innovation Act
Print

Hada Labo Tokyo Skin Care Comes To US Market



Published September 27, 2013
Related Searches: research cosmetics fragrance Skin Care
Post a comment
JAPAN: Rohto Pharmaceutical Co., Ltd., parent of The Mentholatum Company, is bringing Rohto’s popular skin care brand,  Hada Labo Tokyo, to the US. Hada Labo launched in Japan in 2004 and has experienced significant growth across South East Asia, where a bottle its Clear Liquid Hydrator is sold every two seconds, according to the company.

Hada Labo Tokyo is billed as a new generation of lightweight, deeply hydrating, anti-aging skin care promising a beautifully radiant and youthful complexion. The range features Super Hyaluronic Acid, a powerful proprietary combination of three types of hyaluronic acid for multi-layer, long-lasting moisture to effectively restore and strengthen skin’s natural hydrating ability that depletes with age and sun exposure.

The range will be sold at select retailers including all 550 Ulta Stores nationwide and at Drugstore.com; prices range from $11.99-$24.99.

“After extensive consumer research, we have found that the quest for the perfect skin care product is always on women’s minds. Hada Labo Tokyo’s lightweight and deeply hydrating formulas, which are also free of parabens, fragrance, mineral oil and dyes, are extremely appealing to the U.S. consumer,” said Katherine Tocheff, director of marketing and innovation skin care and lip care, The Mentholatum Company, which is a division of Rohto Pharmaceutical Co., Ltd.

Rohto Pharmaceutical Co., Ltd., which markets pharmaceuticals, cosmetics, skin care and health care products, has operations in 12 major markets, with distribution in more than 150 countries globally.

The Mentholatum Company, which was founded in 1889, was acquired by Rohto Pharmaceutical in 1988.

More info: www.mentholatum.com


blog comments powered by Disqus